PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 127 filers reported holding PTC THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 4.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,649,237 | -57.5% | 34,047 | -69.9% | 0.03% | -82.6% |
| Q4 2018 | $3,878,000 | -66.2% | 113,000 | -53.7% | 0.17% | -59.1% |
| Q3 2018 | $11,468,000 | +398.6% | 244,000 | +257.8% | 0.42% | +343.2% |
| Q2 2018 | $2,300,000 | +24.7% | 68,200 | 0.0% | 0.10% | +10.5% |
| Q1 2018 | $1,845,000 | +62.1% | 68,200 | 0.0% | 0.09% | +45.8% |
| Q4 2017 | $1,138,000 | -16.6% | 68,200 | 0.0% | 0.06% | -23.4% |
| Q3 2017 | $1,365,000 | – | 68,200 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |